Knockdown of endogenous LZTS1 caused resistance to paclitaxel in MCF7, MDA-MB231 and T47D breast cancer cells, but not in MDA-MB436 where Lzts1 expression remained unchanged. Here, LZTS1 is linked to breast cancer.